![Jeff Ajer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Ajer
Directeur/Membre du Conseil chez
NEKTAR THERAPEUTICS
Fortune : 160 916 $ au 31/07/2026
Profil
Jeffrey Robert Ajer is currently an Independent Director at Nektar Therapeutics since 2017 and an Independent Director at Viridian Therapeutics, Inc. starting in 2025.
Former positions include Director-Purchasing Worldwide at Bausch Health Americas, Inc. from 1986 to 1999; Senior Director-Sales Operations, Bids & Contracts at SangStat Medical Corp.; Independent Director at True North Therapeutics, Inc.; Chief Commercial Officer & Senior Vice President at BioMarin Pharmaceutical, Inc. from 2012 to 2014; Vice President-Global Transplant Operations at Genzyme Corp.
from 2003 to 2005; and Chief Commercial Officer & Executive Vice President at BioMarin Pharmaceutical, Inc. from 2013 to 2024.
Education includes undergraduate and MBA degrees from the University of California, Irvine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEKTAR THERAPEUTICS 0,01% | 06/04/2026 | 2 277 ( 0,01% ) | 160 916 $ | 31/07/2026 |
| 01/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Jeff Ajer
| Sociétés | Poste | Début |
|---|---|---|
| NEKTAR THERAPEUTICS | Directeur/Membre du Conseil | 21/09/2017 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/03/2025 |
Anciens postes connus de Jeff Ajer
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 20/05/2024 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/08/2005 |
SangStat Medical Corp.
 SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Sales & Marketing | 01/01/2003 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Corporate Officer/Principal | 01/07/1999 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Formation de Jeff Ajer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
SangStat Medical Corp.
SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
